Search Page

1

Cite

Share

Downgrading disease transmission risk estimates using terminal importations.

Fox SJ, Bellan SE, Perkins TA, Johansson MA, Meyers LA. Fox SJ, et al. Among authors: bellan se. PLoS Negl Trop Dis. 2019 Jun 14;13(6):e0007395. doi: 10.1371/journal.pntd.0007395. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31199809 Free PMC article.

Cite

Share

2

Cite

Share

Evaluation of alternative endpoints for ZIKV vaccine efficacy trials.

Mercaldo RA, Bellan SE. Mercaldo RA, et al. Among authors: bellan se. Vaccine. 2019 Apr 3;37(15):2099-2105. doi: 10.1016/j.vaccine.2019.02.066. Epub 2019 Mar 11. Vaccine. 2019. PMID: 30871928 Free PMC article.

Cite

Share

3

Cite

Share

Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection.

Kahn R, Hitchings M, Wang R, Bellan SE, Lipsitch M. Kahn R, et al. Among authors: bellan se. Am J Epidemiol. 2019 Feb 1;188(2):467-474. doi: 10.1093/aje/kwy239. Am J Epidemiol. 2019. PMID: 30329134 Free PMC article.

Cite

Share

4

Cite

Share

How to make epidemiological training infectious.

Bellan SE, Pulliam JR, Scott JC, Dushoff J; MMED Organizing Committee. Bellan SE, et al. PLoS Biol. 2012;10(4):e1001295. doi: 10.1371/journal.pbio.1001295. Epub 2012 Apr 3. PLoS Biol. 2012. PMID: 22509129 Free PMC article.

Cite

Share

5

Cite

Share

Assessing real-time Zika risk in the United States.

Castro LA, Fox SJ, Chen X, Liu K, Bellan SE, Dimitrov NB, Galvani AP, Meyers LA. Castro LA, et al. Among authors: bellan se. BMC Infect Dis. 2017 May 4;17(1):284. doi: 10.1186/s12879-017-2394-9. BMC Infect Dis. 2017. PMID: 28468671 Free PMC article.

Cite

Share

6

Cite

Share

The effect of sexually transmitted co-infections on HIV viral load amongst individuals on antiretroviral therapy: a systematic review and meta-analysis.

Champredon D, Bellan SE, Delva W, Hunt S, Shi CF, Smieja M, Dushoff J. Champredon D, et al. Among authors: bellan se. BMC Infect Dis. 2015 Jun 30;15:249. doi: 10.1186/s12879-015-0961-5. BMC Infect Dis. 2015. PMID: 26123030 Free PMC article. Review.

Cite

Share

7

Cite

Share

Evaluating Ebola vaccine trials: insights from simulation.

Pulliam JRC, Bellan SE, Gambhir M, Meyers LA, Dushoff J. Pulliam JRC, et al. Among authors: bellan se. Lancet Infect Dis. 2015 Oct;15(10):1134. doi: 10.1016/S1473-3099(15)00303-5. Epub 2015 Sep 20. Lancet Infect Dis. 2015. PMID: 26461945 Free PMC article. No abstract available.

Cite

Share

8

Cite

Share

Simulations for designing and interpreting intervention trials in infectious diseases.

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. Halloran ME, et al. Among authors: bellan se. BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3. BMC Med. 2017. PMID: 29287587 Free PMC article.

Cite

Share

9

Cite

Share

An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.

Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr, Brisson M, Mahon BE, Henao-Restrepo AM. Bellan SE, et al. Vaccine. 2019 Jul 18;37(31):4376-4381. doi: 10.1016/j.vaccine.2019.06.019. Epub 2019 Jun 24. Vaccine. 2019. PMID: 31242963 Free PMC article.

Cite

Share

10

Cite

Share

Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Kahn R, Hitchings M, Bellan S, Lipsitch M. Kahn R, et al. Among authors: bellan s. Clin Trials. 2018 Apr;15(2):207-211. doi: 10.1177/1740774517752671. Epub 2018 Jan 27. Clin Trials. 2018. PMID: 29374974 Free PMC article.

Cite

Share